Yuanyuan Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuanyuan Zheng has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Changxiang Yan
Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing, 100093, PR China
1 shared publicationChuan-Ling Hou
Department of Pathology, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing 312000, Zhejiang Province, China
1 shared publication- Chuhui Chen
Department of Endocrinology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital , Fuzhou 350000
1 shared publication - Gang Chen
Fujian Medical University
1 shared publication - Hong Zhang
Renal Division Peking University First Hospital, Peking University Institute of Nephrology Beijing China
1 shared publication Jiexin Zhao
Department of Geriatric Medicine, Fujian Key Laboratory of Geriatrics Diseases, Fujian Provincial Center for Geriatrics, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (28) , e49741
Nonlinear association of remnant cholesterol inflammatory index with metabolic dysfunction-associated steatotic liver disease in US adults: A cross-sectional NHANES study
The remnant cholesterol inflammatory index (RCII) is a composite index whose relationship with metabolic dysfunction-associated steatotic liver disease (MASLD) is uncertain. This research was designed to assess this association. This study involved adults from the 2017–2020 National Health and Nutrition Examination Survey (NHANES) program. Various analytical approaches, including multivariable logistic regression models, restricted cubic splines (RCS), threshold effect analysis, stratified analysis and receiver operating characteristic (ROC) analysis were used to explore the potential link between the RCII and MASLD. The study cohort consisted of 3361 participants, with 1945 (57.87%) diagnosed with MASLD. Adjusted to covariates, a positive correlation between RCII and MASLD was demonstrated through logistic analysis. Both RCS and threshold effect analyses indicated a nonlinear relationship between the RCII and MASLD, with an inflection point of 3.84 for MASLD. ROC analysis revealed that RCII had an area under the curve (AUC) of 0.73 for diagnosing MASLD. The findings reveal a significant association between the RCII and MASLD, proposing its potential value as a clinical biomarker for disease diagnosis.
- 10 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (28) , e49741
Open AccessNonlinear association of remnant cholesterol inflammatory index with metabolic dysfunction-associated steatotic liver disease in US adults: A cross-sectional NHANES study
The remnant cholesterol inflammatory index (RCII) is a composite index whose relationship with metabolic dysfunction-associated steatotic liver disease (MASLD) is uncertain. This research was designed to assess this association. This study involved adults from the 2017–2020 National Health and Nutrition Examination Survey (NHANES) program. Various analytical approaches, including multivariable logistic regression models, restricted cubic splines (RCS), threshold effect analysis, stratified analysis and receiver operating characteristic (ROC) analysis were used to explore the potential link between the RCII and MASLD. The study cohort consisted of 3361 participants, with 1945 (57.87%) diagnosed with MASLD. Adjusted to covariates, a positive correlation between RCII and MASLD was demonstrated through logistic analysis. Both RCS and threshold effect analyses indicated a nonlinear relationship between the RCII and MASLD, with an inflection point of 3.84 for MASLD. ROC analysis revealed that RCII had an area under the curve (AUC) of 0.73 for diagnosing MASLD. The findings reveal a significant association between the RCII and MASLD, proposing its potential value as a clinical biomarker for disease diagnosis.
- Open Access
- 5 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e64634
Metaverse Clinic for Pregnant Women With Subclinical Hypothyroidism: Prospective Randomized Study
Background: Health care is experiencing new opportunities in the emerging digital landscape. The metaverse, a shared virtual space, integrates technologies such as augmented reality, virtual reality, blockchain, and artificial intelligence. It allows users to interact with immersive digital worlds, connect with others, and explore unknowns. While the metaverse is gaining traction across various medical disciplines, its application in thyroid diseases remains unexplored. Subclinical hypothyroidism (SCH) is the most common thyroid disorder during pregnancy and is frequently associated with adverse pregnancy outcomes. Objective: This study aims to evaluate the safety and effectiveness of a metaverse platform in managing SCH during pregnancy. Methods: A randomized controlled trial was conducted at Fujian Provincial Hospital, China, from July 2022 to December 2023. A total of 60 pregnant women diagnosed with SCH were randomly assigned into two groups: the standard group (n=30) and the metaverse group (n=30). Both groups received levothyroxine sodium tablets. Additionally, participants in the metaverse group had access to the metaverse virtual medical consultations and metaverse-based medical games. The primary outcomes were adverse maternal and offspring outcomes, and the secondary outcomes included the neurobehavioral development of offspring and maternal psychological assessments. Results: Of the 30 participants in each group, adverse maternal outcomes were observed in 43% (n=13) of the standard group and 37% (n=11) of the metaverse group (P=.60). The incidence of adverse offspring outcomes was 33% (n=10) in the standard group, compared to 7% (n=2) in the metaverse group (P=.01). The Gesell Development Scale did not show significant differences between the two groups. Notably, the metaverse group demonstrated significantly improved scores on the Self-Rating Depression Scale and the Self-Rating Anxiety Scale scores compared to the standard group (P<.001 and P=.001, respectively). Conclusions: The use of metaverse technology significantly reduced the incidence of adverse offspring outcomes and positively impacted maternal mental health. Maternal adverse outcomes and offspring neurobehavioral development were comparable between the two groups. Trial Registration: Chinese Clinical Trial Registry ChiCTR2300076803; https://www.chictr.org.cn/showproj.html?proj=205905
- 5 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e64634
Open AccessMetaverse Clinic for Pregnant Women With Subclinical Hypothyroidism: Prospective Randomized Study
Background: Health care is experiencing new opportunities in the emerging digital landscape. The metaverse, a shared virtual space, integrates technologies such as augmented reality, virtual reality, blockchain, and artificial intelligence. It allows users to interact with immersive digital worlds, connect with others, and explore unknowns. While the metaverse is gaining traction across various medical disciplines, its application in thyroid diseases remains unexplored. Subclinical hypothyroidism (SCH) is the most common thyroid disorder during pregnancy and is frequently associated with adverse pregnancy outcomes. Objective: This study aims to evaluate the safety and effectiveness of a metaverse platform in managing SCH during pregnancy. Methods: A randomized controlled trial was conducted at Fujian Provincial Hospital, China, from July 2022 to December 2023. A total of 60 pregnant women diagnosed with SCH were randomly assigned into two groups: the standard group (n=30) and the metaverse group (n=30). Both groups received levothyroxine sodium tablets. Additionally, participants in the metaverse group had access to the metaverse virtual medical consultations and metaverse-based medical games. The primary outcomes were adverse maternal and offspring outcomes, and the secondary outcomes included the neurobehavioral development of offspring and maternal psychological assessments. Results: Of the 30 participants in each group, adverse maternal outcomes were observed in 43% (n=13) of the standard group and 37% (n=11) of the metaverse group (P=.60). The incidence of adverse offspring outcomes was 33% (n=10) in the standard group, compared to 7% (n=2) in the metaverse group (P=.01). The Gesell Development Scale did not show significant differences between the two groups. Notably, the metaverse group demonstrated significantly improved scores on the Self-Rating Depression Scale and the Self-Rating Anxiety Scale scores compared to the standard group (P<.001 and P=.001, respectively). Conclusions: The use of metaverse technology significantly reduced the incidence of adverse offspring outcomes and positively impacted maternal mental health. Maternal adverse outcomes and offspring neurobehavioral development were comparable between the two groups. Trial Registration: Chinese Clinical Trial Registry ChiCTR2300076803; https://www.chictr.org.cn/showproj.html?proj=205905
- Open Access
- 16 November 2021
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 9 (32) , 10024-10032
Primary mucosal-associated lymphoid tissue extranodal marginal zone lymphoma of the bladder from an imaging perspective: A case report
Mucosal-associated lymphoid tissue extranodal marginal zone (MALT) lym phoma is a low-grade tumor that rarely occurs in the urinary bladder. There is currently no consensus on the common imaging findings or most appropriate treatment in MALT lymphoma in the urinary bladder due to the limited number of reports. A 48-year-old woman was admitted to the hospital with a 1-year history of macroscopic hematuria. Imaging showed a large homogeneous mass with an unclear boundary and an irregular morphology in the bladder. The mass had an abundant blood supply. For further diagnosis, transurethral cystoscopic biopsy and bone marrow biopsy was performed, and the patient was finally diagnosed with primary MALT lymphoma of the bladder. R-CHOP chemotherapy was carried out. After three cycles of chemotherapy, the mass disappeared and the bladder wall thickness was only 4 mm, which indicated excellent therapeutic response to the chemotherapy. To date, the patient remains asymptomatic and she visits our hospital regularly for the completion of the remaining chemotherapy cycles. Primary MALT lymphoma of the bladder is rare, and there are certain characteristics in the ultrasonographic findings. Imaging findings play an important role in evaluating the therapeutic efficacy and are critical during long-term follow-up after therapy.
- 16 November 2021
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 9 (32) , 10024-10032
Open AccessPrimary mucosal-associated lymphoid tissue extranodal marginal zone lymphoma of the bladder from an imaging perspective: A case report
Mucosal-associated lymphoid tissue extranodal marginal zone (MALT) lym phoma is a low-grade tumor that rarely occurs in the urinary bladder. There is currently no consensus on the common imaging findings or most appropriate treatment in MALT lymphoma in the urinary bladder due to the limited number of reports. A 48-year-old woman was admitted to the hospital with a 1-year history of macroscopic hematuria. Imaging showed a large homogeneous mass with an unclear boundary and an irregular morphology in the bladder. The mass had an abundant blood supply. For further diagnosis, transurethral cystoscopic biopsy and bone marrow biopsy was performed, and the patient was finally diagnosed with primary MALT lymphoma of the bladder. R-CHOP chemotherapy was carried out. After three cycles of chemotherapy, the mass disappeared and the bladder wall thickness was only 4 mm, which indicated excellent therapeutic response to the chemotherapy. To date, the patient remains asymptomatic and she visits our hospital regularly for the completion of the remaining chemotherapy cycles. Primary MALT lymphoma of the bladder is rare, and there are certain characteristics in the ultrasonographic findings. Imaging findings play an important role in evaluating the therapeutic efficacy and are critical during long-term follow-up after therapy.
- Open Access
- 1 May 2019
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 58 (3) , 380-384
Prevalence and causes of cesarean births among women residing at high altitude in Lhasa, Tibet: A retrospective observational study of 7365 women
- 1 May 2019
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 58 (3) , 380-384
Open AccessPrevalence and causes of cesarean births among women residing at high altitude in Lhasa, Tibet: A retrospective observational study of 7365 women
- 1 May 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 499 (3) , 488-492
Comparative toxicity and contrast enhancing assessments of Gd 2 O 3 @BSA and MnO 2 @BSA nanoparticles for MR imaging of brain glioma
- 1 May 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 499 (3) , 488-492
Comparative toxicity and contrast enhancing assessments of Gd 2 O 3 @BSA and MnO 2 @BSA nanoparticles for MR imaging of brain glioma